Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes.

Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C.

J Clin Med. 2019 May 16;8(5). pii: E696. doi: 10.3390/jcm8050696.

2.

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.

Tan SK, Pastori C, Penas C, Komotar RJ, Ivan ME, Wahlestedt C, Ayad NG.

Mol Cancer. 2018 Mar 20;17(1):74. doi: 10.1186/s12943-018-0822-0.

3.

Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.

Jeon Y, Kim H, Jang ES, Hong S, Kim JW, Yoon YS, Cho JY, Han HS, Jeong SH.

APMIS. 2016 Mar;124(3):208-15. doi: 10.1111/apm.12491. Epub 2016 Jan 13.

PMID:
26764243
4.

Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.

Tumour Biol. 2015 Jun;36(6):4643-53. doi: 10.1007/s13277-015-3112-0. Epub 2015 Jan 29.

PMID:
25631748
5.

Analysis of exosome release and its prognostic value in human colorectal cancer.

Silva J, Garcia V, Rodriguez M, Compte M, Cisneros E, Veguillas P, Garcia JM, Dominguez G, Campos-Martin Y, Cuevas J, Peña C, Herrera M, Diaz R, Mohammed N, Bonilla F.

Genes Chromosomes Cancer. 2012 Apr;51(4):409-18.

PMID:
22420032
6.

Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.

Battaglin F, Naseem M, Puccini A, Lenz HJ.

Cancer Cell Int. 2018 Jul 11;18:99. doi: 10.1186/s12935-018-0594-z. eCollection 2018. Review.

7.

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.

Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M, Matsubara H.

Br J Cancer. 2013 Feb 19;108(3):644-52. doi: 10.1038/bjc.2013.8. Epub 2013 Jan 29.

8.

Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.

Fu SJ, Qi CY, Xiao WK, Li SQ, Peng BG, Liang LJ.

Surgery. 2013 Sep;154(3):536-44. doi: 10.1016/j.surg.2013.02.014. Epub 2013 Apr 16.

PMID:
23601901
9.

Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.

Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H.

Cancer. 2013 Mar 15;119(6):1159-67. doi: 10.1002/cncr.27895. Epub 2012 Dec 7.

10.

MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.

Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.

Eur Urol Focus. 2018 Apr;4(3):412-419. doi: 10.1016/j.euf.2016.09.007. Epub 2016 Oct 14.

11.

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.

Chiam K, Wang T, Watson DI, Mayne GC, Irvine TS, Bright T, Smith L, White IA, Bowen JM, Keefe D, Thompson SK, Jones ME, Hussey DJ.

J Gastrointest Surg. 2015 Jul;19(7):1208-15. doi: 10.1007/s11605-015-2829-9. Epub 2015 May 6.

PMID:
25943911
12.

Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.

Yao H, Yang Z, Liu Z, Miao X, Yang L, Li D, Zou Q, Yuan Y.

Cancer Biomark. 2016;17(4):397-404. doi: 10.3233/CBM-160655.

PMID:
27689616
13.

Exosomes, new biomarkers in early cancer detection.

Jalalian SH, Ramezani M, Jalalian SA, Abnous K, Taghdisi SM.

Anal Biochem. 2019 Apr 15;571:1-13. doi: 10.1016/j.ab.2019.02.013. Epub 2019 Feb 15. Review.

PMID:
30776327
14.

Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer.

Herreros-Villanueva M, Bujanda L.

Ann Transl Med. 2016 Feb;4(4):64. doi: 10.3978/j.issn.2305-5839.2015.10.39.

15.

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.

Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R.

Nature. 2015 Jul 9;523(7559):177-82. doi: 10.1038/nature14581. Epub 2015 Jun 24.

16.

Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.

Matsumoto Y, Kano M, Akutsu Y, Hanari N, Hoshino I, Murakami K, Usui A, Suito H, Takahashi M, Otsuka R, Xin H, Komatsu A, Iida K, Matsubara H.

Oncol Rep. 2016 Nov;36(5):2535-2543. doi: 10.3892/or.2016.5066. Epub 2016 Sep 5.

17.

The role of exosome in autoimmune connective tissue disease.

Zhu T, Wang Y, Jin H, Li L.

Ann Med. 2019 Mar;51(2):101-108. doi: 10.1080/07853890.2019.1592215. Epub 2019 Apr 22.

PMID:
30961395
18.

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.

Meng X, Müller V, Milde-Langosch K, Trillsch F, Pantel K, Schwarzenbach H.

Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850.

19.

Exosomes as mediators of intercellular communication: clinical implications.

Nazimek K, Bryniarski K, Santocki M, Ptak W.

Pol Arch Med Wewn. 2015;125(5):370-80. Epub 2015 May 15. Review.

20.

Characteristics and Roles of Exosomes in Cardiovascular Disease.

Zhang Y, Hu YW, Zheng L, Wang Q.

DNA Cell Biol. 2017 Mar;36(3):202-211. doi: 10.1089/dna.2016.3496. Epub 2017 Jan 23. Review.

PMID:
28112546

Supplemental Content

Support Center